Tag: edoxaban
AHA 2024: Edoxaban an “effective alternative” to warfarin following valve replacement surgery
Edoxaban may be an effective alternative to warfarin—the current standard of care—for patients under...
ESC 2021: Edoxaban shown to be noninferior to warfarin for adverse events after TAVI
Edoxaban is noninferior to warfarin and its analogues for adverse clinical events in patients wi...
Virtual ACC: Edoxaban non-inferior to warfarin for preventing thromboembolism after surgical bioprosthetic valve replacement
According to Geu-Ru Hong (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei Univ...
European trial data ‘reinforce’ safety profile and efficacy of Lixiana
Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial ...
Daiichi Sankyo initiates ENVISAGE-TAVI AF study to investigate once-daily edoxaban in atrial fibrillation undergoing TAVI
The ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on...
Daiichi Sankyo begins ENTRUST-AF PCI study of once-daily edoxaban
The first patient has been enrolled into Daiichi Sankyo’s ENTRUST-AF PCI study. The multinational, r...
